Feasibility of automated registration of Patient-Reported Outcome Measures (PROMs) for inguinal hernia surgery : a single-centre pilot study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Automated Collection of Patient-Reported Outcome Measures for Inguinal Hernia Surgery: A Single-Centre Pilot Study of Feasibility

  • By

  • R. R. Meuzelaar

  • H. V. Smit

  • F. P.J. den Hartog

  • A. H.W. Schiphorst

  • P. J. Tanis

  • J. P.J. Burgmans

  • October 15, 2026

Share

  • 1

    The pilot assessed the feasibility of automated patient-reported outcome measure collection through 2 years after elective inguinal hernia repair.

  • 2

    The system sent patients secure automated email invitations to complete brief questionnaires and synchronized responses with the electronic medical record.

  • 3

    The questionnaires covered pain, return to work and exercise, hernia recurrence, and satisfaction with treatment.

  • 4

    The study analyzed a prospective PROMs database from a high-volume hernia clinic, including adults undergoing elective TEP or Lichtenstein repair.

  • 5

    The primary objective was to determine the response rate at each follow-up time point.

Original Source(s)

Feasibility of automated registration of Patient-Reported Outcome Measures (PROMs) for inguinal hernia surgery : a single-centre pilot study

  • by R. R. Meuzelaar, H. V. Smit, F. P.J. den Hartog, A. H.W. Schiphorst, P. J. Tanis, J. P.J. Burgmans

  • October 15, 2026

Related Content

DCIS and Active Monitoring: When Immediate Surgery May Not Be the Only Conversation

The management of ductal carcinoma in situ (DCIS) is entering a period of increasing treatment de-escalation

  • by

  • October 2, 2026

  • 9 min
AI diagnostics and what clinicians can verify in oncology

"The more AI changes what we do … the less able we are to check it.”

FDA expands bladder cancer therapy approval

The expansion offers another treatment option for patients with high-grade tumors following BCG failure.